Ola Granström

934 total citations · 1 hit paper
13 papers, 722 citations indexed

About

Ola Granström is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Ola Granström has authored 13 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 3 papers in Economics and Econometrics and 2 papers in Molecular Biology. Recurrent topics in Ola Granström's work include Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Ola Granström is often cited by papers focused on Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Ola Granström collaborates with scholars based in Sweden, United Kingdom and Netherlands. Ola Granström's co-authors include Kavi J. Littlewood, Goran Medić, Teresa Díez, Kyoko Higashi, Marc D. Binder, Mattias Ekman, Mikael Landén, Phil McEwan, Klas Bergenheim and Martin Henriksson and has published in prestigious journals such as Journal of Affective Disorders, BMJ Open and Social Psychiatry and Psychiatric Epidemiology.

In The Last Decade

Ola Granström

13 papers receiving 703 citations

Hit Papers

Medication adherence in schizophrenia: factors influencin... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
    2013 414 citations Kyoko Higashi, Goran Medić et al. Therapeutic Advances in Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Granström Sweden 8 474 190 132 84 82 13 722
Teresa Díez Spain 12 806 1.7× 324 1.7× 141 1.1× 126 1.5× 29 0.4× 30 1.1k
Joan M. Anzia United States 8 418 0.9× 208 1.1× 112 0.8× 111 1.3× 24 0.3× 16 701
Seung-Hee Hong United States 7 468 1.0× 250 1.3× 89 0.7× 108 1.3× 40 0.5× 10 890
Timothy Peters-Strickland United States 16 680 1.4× 173 0.9× 44 0.3× 171 2.0× 23 0.3× 43 893
Mallik Greene United States 11 455 1.0× 92 0.5× 66 0.5× 64 0.8× 22 0.3× 49 563
JA Cramer United States 7 651 1.4× 213 1.1× 114 0.9× 78 0.9× 20 0.2× 14 891
Kristin A. Cassidy United States 19 781 1.6× 227 1.2× 111 0.8× 27 0.3× 74 0.9× 55 1000
Julie Locklear United States 14 1.0k 2.1× 356 1.9× 150 1.1× 131 1.6× 17 0.2× 38 1.4k
Hans Rittmannsberger Austria 13 341 0.7× 158 0.8× 112 0.8× 61 0.7× 38 0.5× 57 591
Maëlys Touya United States 11 368 0.8× 86 0.5× 81 0.6× 46 0.5× 16 0.2× 29 593

Countries citing papers authored by Ola Granström

Since Specialization
Citations

This map shows the geographic impact of Ola Granström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Granström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Granström more than expected).

Fields of papers citing papers by Ola Granström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Granström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Granström. The network helps show where Ola Granström may publish in the future.

Co-authorship network of co-authors of Ola Granström

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Granström. A scholar is included among the top collaborators of Ola Granström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Granström. Ola Granström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Ekman, Mattias, et al.. (2014). [Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects].. PubMed. 111(34-35). 1362–4. 3 indexed citations
3.
Ekman, Mattias, et al.. (2013). The societal cost of schizophrenia in Sweden.. PubMed. 16(1). 13–25. 31 indexed citations
4.
Ekman, Mattias, et al.. (2013). The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care. Journal of Affective Disorders. 150(3). 790–797. 89 indexed citations
5.
Ekman, Mattias, et al.. (2013). The societal cost of bipolar disorder in Sweden. Social Psychiatry and Psychiatric Epidemiology. 48(10). 1601–1610. 46 indexed citations
6.
Medić, Goran, et al.. (2013). Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Neuropsychiatric Disease and Treatment. 9. 119–119. 44 indexed citations
7.
Higashi, Kyoko, Goran Medić, Kavi J. Littlewood, et al.. (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology. 3(4). 200–218. 414 indexed citations breakdown →
8.
Левин, et al.. (2012). Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension. ClinicoEconomics and Outcomes Research. 4. 313–313. 6 indexed citations
9.
Ekman, Mattias, et al.. (2012). PMH30 The Societal Cost of Depression: Evidence from 10,000 Swedish Patients in Psychiatric Care. Value in Health. 15(4). A87–A87. 1 indexed citations
10.
11.
Granström, Ola, Klas Bergenheim, Phil McEwan, Karin Sennfält, & Martin Henriksson. (2011). Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden. Primary care diabetes. 6(2). 127–136. 39 indexed citations
12.
Ekman, Mattias, et al.. (2010). PMH41 THE SOCIETAL COST OF SCHIZOPHRENIA IN SWEDEN. Value in Health. 13(3). A111–A112. 3 indexed citations
13.
Ekman, Mattias, et al.. (2010). PMH21 SOCIETAL COSTS OF BIPOLAR DISORDER—THE CASE OF SWEDEN. Value in Health. 13(7). A449–A449. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Díez Breakdown of academic impact, for papers by Joan M. Anzia Breakdown of academic impact, for papers by Seung-Hee Hong Breakdown of academic impact, for papers by Timothy Peters-Strickland Breakdown of academic impact, for papers by Mallik Greene Breakdown of academic impact, for papers by JA Cramer Breakdown of academic impact, for papers by Kristin A. Cassidy Breakdown of academic impact, for papers by Julie Locklear Breakdown of academic impact, for papers by Hans Rittmannsberger Breakdown of academic impact, for papers by Maëlys Touya
Rankless by CCL
2026